Jazz Pharmaceuticals relocated its headquarters to Ireland while an aggressive tariff plan caused markets to tank.
5 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jazz Pharmaceuticals relocated its headquarters to Ireland while an aggressive tariff plan caused markets to tank.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
-
Ireland
sovereign state in Northwestern Europe
Related events
Coverage
Newest first; wire copies grouped- StockStory1 Value Stock to Keep an Eye On and 2 Facing Challenges Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out
- StockStoryJazz Pharmaceuticals (NASDAQ:JAZZ) Reports Q2 In Line With Expectations But Stock Drops Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) met Wall Street’s revenue expectations in Q2 CY2025, with
- StockStory3 Healthcare Stocks with Warning Signs Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the
- Unknown outlet